VO-OHPic
Based on 40 publication(s) in Google Scholar
VO-OHPic is a reversible, noncompetitive PTEN inhibitor with an human IC50 value of 46 nM. VO-OHPic inhibits PTEN signaling, activates Akt-GSK3β and Nrf-2/HO-1 pathways, induces apoptosis resistance and elevates IL-10 levels. VO-OHPic inhibits autophagy, ferroptosis and oxidative stress. VO-OHPic can be used for the research of acute myocardial infarction, intervertebral disc degeneration, cardiomyopathy and cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 675848-25-6
- Formel: C12H10N2O8V
- Molecular Weight:361.16
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) VO-OHPic
More- Cell Stem Cell. 2022 Apr 7;29(4):545-558.e13. [Abstract]
- Bone Res. 2018 Nov 10:6:32. [Abstract]
- J Adv Res. 2025 Aug:74:589-607. [Abstract]
- Redox Biol. 2024 Jul:73:103200. [Abstract]
- Redox Biol. 2019 Jan:20:390-401. [Abstract]
- J Nanobiotechnology. 2025 May 25;23(1):376. [Abstract]
- Theranostics. 2019 Jul 9;9(18):5200-5213. [Abstract]
- Theranostics. 2019 Jul 9;9(16):4764-4778. [Abstract]
- Cell Death Dis. 2026 Jan 9;17(1):17. [Abstract]
- Cell Death Dis. 2025 Aug 7;16(1):595. [Abstract]
- Environ Sci Technol. 2020 Sep 1;54(17):10783-10796. [Abstract]
- Cell Death Dis. 2019 Apr 15;10(5):329. [Abstract]
- Phytomedicine. 2023 Dec:121:155117. [Abstract]
- Int J Mol Med. 2021 Jun;47(6):109. [Abstract]
- Clin Transl Med. 2022 Sep;12(9):e1061. [Abstract]
- Clin Transl Med. 2020 Dec;10(8):e240. [Abstract]
- Stem Cell Res Ther. 2019 Jul 29;10(1):217. [Abstract]
- Transl Psychiatry. 2021 Mar 26;11(1):185. [Abstract]
- Biochem Pharmacol. 2020 Jan:171:113715. [Abstract]
- Biochem Pharmacol. 2019 Oct:168:82-90. [Abstract]
- Commun Biol. 2026 Jan 23;9(1):311. [Abstract]
- Cell Biol Toxicol. 2025 Feb 27;41(1):53. [Abstract]
- Int J Mol Sci. 2023 Jun 9;24(12):9954. [Abstract]
- Int Immunopharmacol. 2022 Feb:103:107840. [Abstract]
- Channels. 2026 Jun 22;20(1).
- Mol Med Rep. 2022 Jul;26(1):246. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166292. [Abstract]
- Mol Med Rep. 2018 Dec;18(6):5489-5501. [Abstract]
- Mol Cell Biochem. 2026 May;481(5):2119-2137. [Abstract]
- J Cell Mol Med. 2019 Nov;23(11):7535-7544. [Abstract]
- iScience. 2024 Jun 19;27(7):110306. [Abstract]
- Mol Nutr Food Res. 2019 Dec;63(24):e1900418. [Abstract]
- BMC Cancer. 2019 Apr 25;19(1):391. [Abstract]
- Funct Integr Genomics. 2024 Apr 3;24(2):71. [Abstract]
- Cancer Med. 2019 Aug;8(9):4265-4277. [Abstract]
- Mol Vis. 2018 Jul 23:24:485-494. [Abstract]
- McGill University. 2026.
- Res Sq. 2026 Apr 30.
- SSRN. 2023 Jul 17.
- Eur Rev Med Pharmacol Sci. 2019 May;23(10):4406-4413. [Abstract]
-
WB
-
WB
-
WB
-
WB
-
WB
Biologische Aktivität
Beschreibung
|
Akt |
IL-10 |
In Vitro
VO-OHpic (0.05-2.0 μg/mL; 2 h) dose-dependently improves viability of H/R-stressed isolated adult rat cardiac myocytes[1].
VO-OHpic (1 µM; 24-72 h) suppresses the proliferation of TSC2-/- MEFs in a time-dependent manner[2].
VO-OHpic (1 µM; 24-72 h) excessively inhibits autophagy in TSC2-/- MEFs[2].
VO-OHpic (1 µM; 24-72 h) modulates the PTEN/PRAS40 pathway in TSC2-/- MEFs[2].
VO-OHPic (1 μM; 24 h) inhibits TBHP-induced ferroptosis by restoring GPX4 and SLC7A11 expression in primary mouse CEP chondrocytes[3].
VO-OHPic (1 μM; 24 h) inhibits TBHP-induced ROS production in primary mouse CEP chondrocytes[3].
VO-OHPic (30 μM) alleviates IL-1β-induced degeneration in human nucleus pulposus cells by inhibiting PTEN and activating the PI3K/Akt pathway, thereby restoring collagen II and aggrecan levels[4].
VO-OHPic (30 μM) promotes proliferation in IL-1β-induced degenerated human nucleus pulposus cells by mediating cell cycle progression through the G1 to S phase[4].
VO-OHPic (30 μM) reduces oxidative stress in H2O2-induced degenerated human nucleus pulposus cells by lowering ROS levels and upregulating antioxidant enzymes SOD1, SOD2, CAT, and GSH[4].
VO-OHPic (1 μM; 48 h) activates the Nrf2 signaling pathway in Methylprednisolone (HY-B0260) -treated rat endothelial progenitor cells by increasing expression of Nrf2 and its downstream antioxidant proteins, and promoting Nrf2 nuclear translocation[5].
VO-OHPic (1 μM; 48 h) restores normal mitochondrial morphology in Methylprednisolone-treated rat endothelial progenitor cells[5].
VO-OHPic (1 μM; 48 h) suppresses Methylprednisolone-induced excessive reactive oxygen species generation in rat endothelial progenitor cells[5].
VO-OHPic (1 μM; 48 h) requires activation of Nrf2 to exert anti-apoptotic, antioxidant, and pro-angiogenic effects in Methylprednisolone-treated rat endothelial progenitor cells[5].
VO-OHpic (15-300 nM; 10 min) reversibly inhibits purified recombinant PTEN in a noncompetitive manner with an IC50 of 46 nM[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:TSC2-/- murine embryonic fibroblasts (MEFs)
-
Concentration:1 µM
-
Incubation Time:24 h; 48 h; 72 h
-
Result:Reduced relative cell viability significantly at 48 h (P=0.005) and 72 h (P<0.001).
Showed no significant difference in relative cell viability at 24 h (P=0.333).
-
Cell Line:TSC2-/- murine embryonic fibroblasts (MEFs)
-
Concentration:1 µM
-
Incubation Time:24 h; 48 h; 72 h
-
Result:Reduced relative expression of LC3-I significantly at 24 h (P<0.001), 48 h (P=0.015), and 72 h (P=0.001).
Reduced relative expression of LC3-II significantly at 24 h (P=0.020), 48 h (P<0.001), and 72 h (P=0.007).\nReduced relative expression ratio of p-PTEN/PTEN significantly at 24 h (P=0.001), 48 h (P=0.005), and 72 h (P=0.011).
Reduced relative expression ratio of p-PRAS40/PRAS40 significantly at 48 h (P<0.001) and 72 h (P<0.001).
Showed no significant difference in relative expression ratio of p-PRAS40/PRAS40 at 24 h (P=0.137).
-
Cell Line:human nucleus pulposus (NP) cells
-
Concentration:10 μM; 30 μM; 50 μM; 100 μM
-
Incubation Time:48 h
-
Result:Achieves the highest cell viability at 30 μM compared to all other tested concentrations.
-
Cell Line:rat endothelial progenitor cells (EPCs)
-
Concentration:1 μM
-
Incubation Time:48 h
-
Result:Reversed MPS-induced increases in cleaved caspase-3, cleaved caspase-9, cytochrome C, and Bax protein expression.
Restored MPS-reduced Bcl-xL expression and the p-Bad/Bad ratio.
Suppressed MPS-promoted formation of the Bad/Bcl-xL pro-apoptotic complex.
Attenuated MPS-induced Bax translocation to mitochondria and cytochrome C release from mitochondria to cytoplasm.\nReversed MPS-induced reductions in SIRT1, Nrf2, HO-1, NQO-1, and Trx protein expression.
Increased nuclear Nrf2 localization, which was suppressed by MPS.
-
Cell Line:rat endothelial progenitor cells (EPCs)
-
Concentration:1 μM
-
Incubation Time:48 h
-
Result:Significantly increased VEGF concentration in the culture medium relative to the MPS-only group, reversing MPS-suppressed EPC VEGF secretion.
In Vivo
VO-OHpic (10 mg/kg; i.p.; every 2 days) attenuates LPS (HY-D1056)- and Methylprednisolone-induced osteonecrosis of the femoral head in rats, increases bone volume parameters, reduces empty bone lacunae, and promotes angiogenesis in the femoral head[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (8-week-old male; surgically induced intervertebral disc instability)[3]
-
Dosage:10 mg/kg
-
Administration:i.p.; every other day; 12 weeks
-
Result:Reduced intervertebral disc degeneration histological score significantly compared to the IDD-only group.
Improved intervertebral disc height significantly compared to the IDD-only group.
Reduced bone volume/tissue volume (BV/TV) of the cartilage endplate significantly compared to the IDD-only group.
Increased COL2-positive cell levels in the cartilage endplate compared to the IDD-only group.
Decreased MMP3-positive cell levels in the cartilage endplate compared to the IDD-only group.
Increased Nrf-2-positive cell levels in the cartilage endplate compared to the IDD-only group.
Reduced COL10 and OCN-positive cell levels in the cartilage endplate compared to the IDD-only group.
-
Animal Model:Sprague-Dawley (male, 7 weeks old, body weight 250-300 g, osteonecrosis of the femoral head model induced by LPS + Methylprednisolone)[5]
-
Dosage:10 mg/kg
-
Administration:i.p.; every 2 days
-
Result:Significantly increased bone volume and bone volume/total volume compared to the methylprednisolone-only group.
Decreased bone surface/trabecular bone volume compared to the methylprednisolone-only group.
Reduced the number of empty bone lacunae in the femoral head compared to the methylprednisolone-only group.
Increased the relative staining intensity of CD31, VEGF, and VEGFR2 in subchondral bone trabeculae compared to the methylprednisolone-only group.
Increased the number of CD31-positive and VEGFR2-positive blood vessels per field compared to the methylprednisolone-only group.
Chemical Information
-
CAS. Nr. 675848-25-6
-
Molecular Weight 361.16
-
Formel C12H10N2O8V
-
SMILES
[OH2][V+2]([N]1=CC=CC(O)=C1C2=O)([O-]2)([O-]C3=CC=CN=C3C4=O)([O-]4)=O.[H+]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (40)
-
Journal Impact Factor
-
Most Recent
-
Cell Stem Cell
A small-molecule cocktail promotes mammalian cardiomyocyte proliferation and heart regeneration. [Abstract]2022 Apr 7;29(4):545-558.e13. PMID: 35395187 -
Bone Res
NUMB maintains bone mass by promoting degradation of PTEN and GLI1 via ubiquitination in osteoblasts. [Abstract]2018 Nov 10:6:32. PMID: 30455992 -
J Adv Res
Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. [Abstract]2025 Aug:74:589-607. PMID: 39353532 -
Redox Biol
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. [Abstract]2024 Jul:73:103200. PMID: 38781729 -
Redox Biol
Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. [Abstract]2019 Jan:20:390-401. PMID: 30412827
VO-OHPic purchased from MedChemExpress. Usage Cited in: Redox Biol. 2019 Jan:20:390-401. [Abstract]
Western analysis of related genes expression in mice with the treatment of TAC, TAC+RES, and TAC+RES+VO-Ophic.
VO-OHPic purchased from MedChemExpress. Usage Cited in: Redox Biol. 2019 Jan:20:390-401. [Abstract]
Immunoblotting analysis show that RES treatment markedly inhibited Ang II-induced degradation of PTEN, activation of AKT and mTOR and inactivation of AMPK, but this effect is reversed by VO-OHpic.
VO-OHPic purchased from MedChemExpress. Usage Cited in: Redox Biol. 2019 Jan:20:390-401. [Abstract]
Immunoblotting analysis show that RES treatment markedly inhibited Ang II-induced degradation of PTEN, activation of AKT and mTOR and inactivation of AMPK, but this effect is reversed by VO-OHpic.
-
J Nanobiotechnology
An orally-administered nanotherapeutics with gold nanospheres supplying for rheumatoid arthritis therapy by re-shaping gut microbial tryptophan metabolism. [Abstract]2025 May 25;23(1):376. PMID: 40414887 -
Theranostics
Spontaneous evolution of human skin fibroblasts into wound-healing keratinocyte-like cells. [Abstract]2019 Jul 9;9(18):5200-5213. PMID: 31410210 -
Theranostics
Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma. [Abstract]2019 Jul 9;9(16):4764-4778. PMID: 31367256 -
Cell Death Dis
ZC3H15 regulates the ubiquitination of PTEN via recruitment of TRIM56 and promotes malignant progression of non-small cell lung cancer. [Abstract]2026 Jan 9;17(1):17. PMID: 41513632 -
Cell Death Dis
Activation of AKT via a dual mechanism enhances the susceptibility of melanoma cells to glucose deprivation. [Abstract]2025 Aug 7;16(1):595. PMID: 40774947 -
Environ Sci Technol
Tris(1,3-dichloro-2-propyl)phosphate Reduces the Lifespan via Activation of an Unconventional Insulin/Insulin-Like Growth Factor-1 Signaling Pathway. [Abstract]2020 Sep 1;54(17):10783-10796. PMID: 32786597 -
Cell Death Dis
S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway. [Abstract]2019 Apr 15;10(5):329. PMID: 30988280 -
Phytomedicine
Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics. [Abstract]2023 Dec:121:155117. PMID: 37820467 -
Int J Mol Med
Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway. [Abstract]2021 Jun;47(6):109. PMID: 33907827 -
Clin Transl Med
PARK7 deficiency inhibits fatty acid β-oxidation via PTEN to delay liver regeneration after hepatectomy. [Abstract]2022 Sep;12(9):e1061. PMID: 36149763 -
Clin Transl Med
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity. [Abstract]2020 Dec;10(8):e240. PMID: 33377656 -
Stem Cell Res Ther
Mouse embryonic palatal mesenchymal cells maintain stemness through the PTEN-Akt-mTOR autophagic pathway. [Abstract]2019 Jul 29;10(1):217. PMID: 31358051
VO-OHPic purchased from MedChemExpress. Usage Cited in: Stem Cell Res Ther. 2019 Jul 29;10(1):217. [Abstract]
Western blot showing the levels of phosphorylated and non-phosphorylated PTEN, AKT, and mTOR proteins before and after VO-OHpic trihydrate treatment.
-
Transl Psychiatry
2021 Mar 26;11(1):185. PMID: 33771972 -
Biochem Pharmacol
Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. [Abstract]2020 Jan:171:113715. PMID: 31751538 -
Biochem Pharmacol
2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation. [Abstract]2019 Oct:168:82-90. PMID: 31229551 -
Commun Biol
DTX1-mediated degradation of TUBB3 in Kupffer cells mitigates hepatocellular carcinoma progression by regulating M1/M2 polarization. [Abstract]2026 Jan 23;9(1):311. PMID: 41577987 -
Cell Biol Toxicol
Glycolysis regulates palatal mesenchyme proliferation through Pten-Glut1 axis via Pten classical and non-classical pathways. [Abstract]2025 Feb 27;41(1):53. PMID: 40014184 -
Int J Mol Sci
PTEN Inhibitor Treatment Lowers Muscle Plasma Membrane Damage and Enhances Muscle ECM Homeostasis after High-Intensity Eccentric Exercise in Mice. [Abstract]2023 Jun 9;24(12):9954. PMID: 37373102 -
Int Immunopharmacol
USP20 mitigates ischemic stroke in mice by suppressing neuroinflammation and neuron death via regulating PTEN signal. [Abstract]2022 Feb:103:107840. PMID: 34953448 -
-
Mol Med Rep
LncRNA LINC00961 regulates endothelial‑mesenchymal transition via the PTEN‑PI3K‑AKT pathway. [Abstract]2022 Jul;26(1):246. PMID: 35656895 -
Biochim Biophys Acta Mol Basis Dis
Mycobacterium tuberculosis ESAT6 modulates host innate immunity by downregulating miR-222-3p target PTEN. [Abstract]2022 Jan 1;1868(1):166292. PMID: 34710568 -
Mol Med Rep
miR‑371b‑5p inhibits endothelial cell apoptosis in monocrotaline‑induced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways. [Abstract]2018 Dec;18(6):5489-5501. PMID: 30387816 -
Mol Cell Biochem
S-equol promotes ferroptosis in triple negative breast cancer by coordinating NCOA4-mediated ferritinophagy and PPARγ-mediated lipid metabolism. [Abstract]2026 May;481(5):2119-2137. PMID: 41925800 -
J Cell Mol Med
Aspirin inhibits adipogenesis of tendon stem cells and lipids accumulation in rat injury tendon through regulating PTEN/PI3K/AKT signalling. [Abstract]2019 Nov;23(11):7535-7544. PMID: 31557405 -
iScience
Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cells. [Abstract]2024 Jun 19;27(7):110306. PMID: 39055915 -
Mol Nutr Food Res
Resveratrol Attenuates Pressure Overload-Induced Cardiac Fibrosis and Diastolic Dysfunction via PTEN/AKT/Smad2/3 and NF-κB Signaling Pathways. [Abstract]2019 Dec;63(24):e1900418. PMID: 31655498 -
BMC Cancer
Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer. [Abstract]2019 Apr 25;19(1):391. PMID: 31023264 -
Funct Integr Genomics
MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway. [Abstract]2024 Apr 3;24(2):71. PMID: 38568332 -
Cancer Med
Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway. [Abstract]2019 Aug;8(9):4265-4277. PMID: 31173492 -
Mol Vis
2018 Jul 23:24:485-494. PMID: 30967746
VO-OHPic purchased from MedChemExpress. Usage Cited in: Mol Vis. 2018 Jul 23:24:485-494. [Abstract]
The miR-21 inhibitor promotes the expression of the PTEN protein and inhibits the expression of p-AKT, and VO-Ohpic trihydrate reverses the effect.
-
-
-
-
Eur Rev Med Pharmacol Sci
2019 May;23(10):4406-4413. PMID: 31173315
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Reinheit & Dokumentation
Verweise
[1]. Li Z, et al. PTEN signaling inhibitor VO-OHpic improves cardiac myocyte survival by mediating apoptosis resistance in vitro. Biomed Pharmacother. 2018;103:1217-1222. [Content Brief]
[2]. Wang W, et al. PTEN inhibitor VO-OHpic suppresses TSC2-/- MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathway. Exp Ther Med. 2020;19(6):3565-3570. [Content Brief]
[3]. Cui X, et al. PTEN inhibitor VO-OHpic protects endplate chondrocytes against apoptosis and calcification via activating Nrf-2 signaling pathway. Aging (Albany NY). 2023;15(6):2275-2292. [Content Brief]
[4]. Lin Y, et al. VO-OHpic attenuates intervertebral disc degeneration via PTEN/Akt pathway. Eur Rev Med Pharmacol Sci. 2020;24(6):2811-2819. [Content Brief]
[5]. Yao X, et al. PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway. Stem Cell Res Ther. 2020;11(1):140. Published 2020 Mar 30. [Content Brief]
[6]. Mak LH, et al. Characterisation of the PTEN inhibitor VO-OHpic. J Chem Biol. 2010;3(4):157-163. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- VO-OHPic
- 675848-25-6
- PTEN
- Apoptosis
- Autophagy
- Ferroptosis
- Reactive Oxygen Species (ROS)
- Interleukin Related
- Akt
- Keap1-Nrf2
- Akt-GSK3β
- Nrf-2/HO-1
- primary mouse CEP chondrocytes
- human nucleus pulposus cells
- rat endothelial progenitor cells
- acute myocardial infarction
- intervertebral disc degeneration
- adult rat cardiac myocytes
- TSC2-/- MEFs
- Inhibitor
- inhibitor
- inhibit